Patents matching “The United States of America”

US 9598471

Bacteriocin with novel activity

The United States of America, as represented by the Secretary of Agriculture · Granted Mar 21, 2017 · Expires Mar 16, 2037

US 9598703

Capsid-free AAV vectors, compositions, and methods for vector production and gene delivery

THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES, NATIONAL INSTITUTES OF HEALTH · Granted Mar 21, 2017 · Expires Mar 16, 2037

US 9598441

Therapeutic compounds and methods

The United States of America as represented by the Department of Veteran Affairs · Granted Mar 21, 2017 · Expires Mar 16, 2037

US 9598492

Human monoclonal antibodies specific for CD22

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Mar 21, 2017 · Expires Mar 16, 2037

US 9593136

Compounds for inhibiting 1-deoxy-D-xylulose-5-phosphate reductoisomerase

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 14, 2017 · Expires Mar 9, 2037

US 9592304

Recombinant antibodies and immunoconjugates targeted to CD-22 bearing cells and tumors

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Mar 14, 2017 · Expires Mar 9, 2037

US 9592207

Intranasal administration of ketamine to treat depression

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 14, 2017 · Expires Mar 9, 2037

US 9587232

Mutated organophosphorus acid anhydrolases and their uses thereof

The United States of America as represented by the Secretary of the Army · Granted Mar 7, 2017 · Expires Mar 2, 2037

US 9579333

Inhibition of HIV infection through chemoprophyalxis

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 28, 2017 · Expires Feb 23, 2037

US 9580492

Monoclonal antibodies that neutralize anthrax toxins

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 28, 2017 · Expires Feb 23, 2037

US 9579302

Ketone bodies to protect tissues from damage by ionizing radiation

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 28, 2017 · Expires Feb 23, 2037

US 9567566

HMGN polypeptides as immune enhancers and HMGN antagonists as immune suppressants

The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Feb 14, 2017 · Expires Feb 9, 2037

US 9567387

T cell receptors and related materials and methods of use

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 14, 2017 · Expires Feb 9, 2037

US 9566329

Live, attenuated rubella vector to express vaccine antigens

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 14, 2017 · Expires Feb 9, 2037

US 9562237

Reduction of TGF beta signaling in myeloid cells in the treatment of cancer

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 7, 2017 · Expires Feb 2, 2037

US 9555064

Protease-deficient Bacillus anthracis

The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Jan 31, 2017 · Expires Jan 26, 2037

US 9556237

Antiviral rift valley fever virus peptides and methods of use

The United States of America, as represented by the Secretary of the Army, on behalf of the U.S. Army Medical Research Institute of Infectious Diseases · Granted Jan 31, 2017 · Expires Jan 26, 2037

US 9555090

Equine encephalitis virus vaccines and methods of using thereof

The United States of America as repesented by the Secretary of Army, on behalf of the U.S. Army Medical Research Institute of Infections Diseases · Granted Jan 31, 2017 · Expires Jan 26, 2037

US 9556244

Vaccination of animals to elicit a protective immune response against tick infestations and tick-borne pathogen transmission

The United States of America, as represented by the Secretary of Agriculture · Granted Jan 31, 2017 · Expires Jan 26, 2037

US 9550742

11-OXO-10,11-dihydrodibenzo[B,F][1,4]thiazepine S-oxide derivatives and their use as dopamine D2 receptor antagonists

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 24, 2017 · Expires Jan 19, 2037

US 9549975

Genetically engineered swine influenza virus and uses thereof

The United States of America, as represented by the Secretary of Agriculture · Granted Jan 24, 2017 · Expires Jan 19, 2037

US 9550818

Methods for use of vascular endothelial growth factor antagonists

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 24, 2017 · Expires Jan 19, 2037

US 9545431

Isolated recombinant cDNA

The United States of America, as represented by the Secretary of Agriculture · Granted Jan 17, 2017 · Expires Jan 12, 2037

US 9546151

VMAT inhibitory compounds

The United States of America as represented by the Department of Veteran Affairs · Granted Jan 17, 2017 · Expires Jan 12, 2037